Jian Xie - Nov 29, 2021 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Chief Operating Officer
Signature: /s/ Paul Kim as Attorney-in-Fact
Stock symbol: FLGT
Transactions as of: Nov 29, 2021
Transactions value $: -$60,686
Form type: 4
Date filed: 12/1/2021, 04:20 PM
Previous filing: Nov 18, 2021
Next filing: Feb 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Sale	-$60.7K	-636	-0.21%	$95.42	303K	Nov 29, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019.
F2	The shares were sold in multiple transactions at prices ranging from $94.4300 to $96.5100, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Content

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019.

The shares were sold in multiple transactions at prices ranging from $94.4300 to $96.5100, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.